Sundu Brahmasandra

Member, Technical Advisory Board at Arboretum Ventures

Sundu Brahmasandra is an accomplished serial entrepreneur and brings more than 20 years of impressive leadership in all aspects of novel IVD product development, strategic planning, and operational management. Most recently Sundu was the COO of Strata Oncology. Prior to Strata, Sundu was the President & COO of NeuMoDx Molecular where he led the development of a multitude of molecular diagnostics assays on the revolutionary NeuMoDx 288 and NeuMoDx 96 Molecular Systems. NeuMoDx was acquired by QIAGEN in 2020. Prior to NeuMoDx Sundu co-founded HandyLab, Inc and led the development of the HandyLab Jaguar (aka BD MAX) System. HandyLab was acquired by BD in 2009.

Sundu holds a B.Tech in Chemical Engineering from IIT-Madras and a PhD in Chemical Engineering from the University of Michigan, Ann Arbor.

Links


Org chart

This person is not in the org chart


Teams

This person is not in any teams